| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.13 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |